𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Limitation of Myocardial Reperfusion Injury by AMP579, an Adenosine A1/A2AReceptor Agonist: Role of A2AReceptor and Erk1/2

✍ Scribed by Adrienn Kis; Gary F. Baxter; Derek M. Yellon


Book ID
111575879
Publisher
Springer US
Year
2003
Tongue
English
Weight
230 KB
Volume
17
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacological characterization of AMP
✍ Linda Merkel; Camilo J. Rojas; Michael F. Jarvis; Bryan F. Cox; Cynthia Fink; Gl πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 302 KB πŸ‘ 1 views

2Ξ²,3Ξ²,4Ξ±(S\*) ]-4-[7- [[1-[(3-chloro-2-thienyl)methyl]propylamino]-3Himidazo [4,5-b]pyridin-3-yl]-N-ethyl-2,3-dihydroxy cyclopentanecarboxamide) is a novel cardioprotective adenosine agonist with the following order of affinity at adenosine receptors: A 1 > A 2A > A 3 . Agonism at A 1 receptors was